COST-EFFECTIVENESS OF THE CELL-BASED QUADRIVALENT VERSUS THE STANDARD EGG-BASED QUADRIVALENT INFLUENZA VACCINE IN GERMANY.

Cai, R; Eichner, M; Schwehm, M; Rajaram, S; Joaquin, FMQ; Lamotte, M

VALUE IN HEALTH, 2020; 23 (): S548